Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (610)	6/10/1998 8:50:00 AM
From: chirodoc	Respond to of 6039

Arch Surg 1998 May;133(5):504-507 A prospective analysis of office-based breast ultrasound. <<<<so don't sweat the small stuff Chirodoc. ........sometimes diggin' gits us fool's gold. but knowin' it is a new registration and not new shares is helpful. you wouldn't want to have a nuuget in your pocket with the price of gold droppin' by 1/2 would ya. .........anyway, this article is the big stuff. <<<<< (75%) of 96 sonographically suspicious lesions proved to be cancer (including 13 cases with normal mammograms) ......75% is for suspicious only--means they still need a biopsy. go coii! curtis Hieken TJ, Velasco JM Department of Surgery, Rush North Shore Medical Center, Skokie, Ill 60076, USA. [Medline record in process] OBJECTIVE: To determine the usefulness of office-based breast ultrasound. DESIGN: Prospective, nonrandomized study. SETTING: Academic-affiliated community teaching hospital. PATIENTS: Among 653 consecutive patients seen in our office during a 30-month period, we performed 660 ultrasound examinations. The presenting complaint included a palpable mass in 53%, abnormal mammogram in 39%, and nipple discharge or retraction in 3%. INTERVENTION: Ultrasound examination was performed using a handheld 7.5-MHz linear array transducer. Findings and pertinent clinicopathologic data were recorded prospectively in our Breast Ultrasound Registry. MAIN OUTCOME MEASURE: Contribution of breast ultrasound to diagnosis and treatment. RESULTS: The sonogram was normal in 201 cases (30%), showed duct ectasia in 20 cases (3%), a simple cyst or seroma in 101 cases (15%), and a focal complex or solid abnormality in 338 cases (51%). Among the last group, 114 (97%) of 118 lesions thought to be benign on ultrasonography proved to be benign, whereas 13 (12%) of 111 indeterminate and 72 (75%) of 96 sonographically suspicious lesions proved to be cancer (including 13 cases with normal mammograms). Ultrasonographic features of malignancy included an anteroposterior-to-lateral dimension ratio of 1 or greater, heterogeneous hypoechoicity, irregular shadowing, and fuzzy and/or jagged margins. Ultrasound-guided needle biopsy accurately diagnosed 46 benign nonpalpable lesions and 20 malignant nonpalpable lesions. CONCLUSIONS: These data suggest that ultrasonography is a useful adjunct to clinical and mammographic evaluation of breast disease. Breast ultrasound identifies cysts, aids in differentiating benign from malignant lesions, and facilitates office needle biopsy of nonpalpable abnormalities, permitting timely and cost-effective patient care.